VOYA Investment Management
IBIO icon

VOYA Investment Management’s iBio IBIO Stock Holding History

VOYA Investment Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-163
Closed -$35K – 2825
2022
Q1 		$35K Hold
163
– – ﹤0.01% 2620
2021
Q4 		$45K Sell
163
-8
-5% -$3.05K ﹤0.01% 2749
2021
Q3 		$91K Hold
171
– – ﹤0.01% 2755
2021
Q2 		$129K Sell
171
-16
-9% -$11.7K ﹤0.01% 2721
2021
Q1 		$144K Buy
187
+33
+21% +$28.8K ﹤0.01% 2606
2020
Q4 		$81K Buy
154
+112
+267% +$91.2K ﹤0.01% 2597
2020
Q3 		$42K Sell
42
-12
-22% -$17.4K ﹤0.01% 2447
2020
Q2 		$60K Buy
+54
New +$35.3K ﹤0.01% 2426

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VOYA Investment Management's IBIO Position: Q2 2022 in Review

VOYA Investment Management sold out of iBio (IBIO) in Q2 2022, closing a stake of 163 shares — an estimated $35K sold.

VOYA Investment Management first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $144K in Q1 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • VOYA Investment Management reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 163 iBio shares in Q2 2022, an estimated $35K.
  • VOYA Investment Management first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • VOYA Investment Management's iBio position peaked at $144K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.